Potential delayed and/or missed STI diagnoses among outpatients presenting with lower genitourinary tract symptoms: a real-world database study

References

• Centers for Disease Control and Prevention. National overview of STDs, 2021. 2023 [updated May 16, 2023; cited Jun 12, 2023]. Available from: https://www.cdc.gov/std/statistics/2021/overview.htm
   Google Scholar
• Behzadi P, Behzadi E, Pawlak-Adamska EA. Urinary tract infections (UTIs) or genital tract infections (GTIs)? it’s the diagnostics that count. GMS Hyg Infect Control. 2019;14:Doc14. doi: 10.3205/dgkh000320
   PubMed Web of Science ®Google Scholar
• Tomas ME, Getman D, Donskey CJ, et al. Overdiagnosis of urinary tract infection and underdiagnosis of sexually transmitted infection in adult women presenting to an emergency department. J Clin Microbiol. 2015;53(8):2686–2692.
   PubMed Web of Science ®Google Scholar
• Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187.
   PubMed Web of Science ®Google Scholar
• Tuddenham S, Hamill MM, Ghanem KG. Diagnosis and treatment of sexually transmitted infections: a review. JAMA. 2022;327(2):161–172. doi: 10.1001/jama.2021.23487
   PubMed Web of Science ®Google Scholar
• Lillis R, Kuritzky L, Huynh Z, et al. Outpatient sexually transmitted infection testing and treatment patterns in the United States: a real-world database study. BMC Infect Dis. 2023;23(1):469.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Adult outpatient treatment recommendations. 2017 [updated 2017 Oct 3; cited 2023 Jan 3]. Available from: https://www.cdc.gov/antibiotic-use/clinicians/adult-treatment-rec.html
   Google Scholar
• Workowski KA, Bolan GA, Centers for Disease C, et al. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR–03):1–137.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2020: gonococcal isolate surveillance project profile. 2022 [cited 2023 Jun 12]. Available from: https://www.cdc.gov/std/statistics/gisp-profiles/gisp_profiles_national_final.pdf
   Google Scholar
• Centers for Disease Control and Prevention. Update to CDC’s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007;56(14):332–336 .
   PubMedGoogle Scholar
• Bui T, Preuss CV. Cephalosporins. StatPearls. Treasure Island (FL): StatPearls Publishing. Copyright © 2022, StatPearls Publishing LLC; 2022.
   Google Scholar
• St Cyr S, Barbee L, Workowski KA, et al. Update to CDC’s treatment guidelines for gonococcal infection, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1911–1916.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. U.S. STI epidemic showed no signs of slowing in 2021. 2023 [updated 2023 Apr 11; cited 2023 Apr 11]. Available from: https://www.cdc.gov/nchhstp/newsroom/2023/2021-STD-surveillance-report.html
   Google Scholar
• Davidson KW, Barry MJ, Mangione CM, et al. Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(10):949–956.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Screening recommendations and considerations referenced in treatment guidelines and original sources. 2021 [updated 2022 Jun 6; cited 2023 Jun 6]. Available from: https://www.cdc.gov/std/treatment-guidelines/screening-recommendations.htm
   Google Scholar
• Moore A, Traversy G, Reynolds DL, et al. Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk. CMAJ. 2021;193(16):E549–E559.
   PubMed Web of Science ®Google Scholar
• Grennan T, Tan DHS. Benefits of opportunistic screening for sexually transmitted infections in primary care. CMAJ. 2021;193(16):E566–E567. doi: 10.1503/cmaj.210604
   PubMed Web of Science ®Google Scholar
• Huppert JS, Biro F, Lan D, et al. Urinary symptoms in adolescent females: STI or UTI? J Adolesc Health. 2007;40(5):418–424.
   PubMed Web of Science ®Google Scholar
• Shapiro T, Dalton M, Hammock J, et al. The prevalence of urinary tract infections and sexually transmitted disease in women with symptoms of a simple urinary tract infection stratified by low colony count criteria. Acad Emerg Med. 2005;12(1):38–44.
   PubMed Web of Science ®Google Scholar
• Prentiss KA, Newby PK, Vinci RJ. Adolescent female with urinary symptoms: a diagnostic challenge for the pediatrician. Pediatr Emerg Care. 2011;27(9):789–794. doi: 10.1097/PEC.0b013e31822c10f6
   PubMed Web of Science ®Google Scholar
• Wilbanks MD, Galbraith JW, Geisler WM. Dysuria in the emergency department: missed diagnosis of Chlamydia trachomatis. West J Emerg Med. 2014;15(2):227–230. doi: 10.5811/westjem.2013.12.18989
   PubMedGoogle Scholar
• Musacchio NS, Gehani S, Garofalo R. Emergency department management of adolescents with urinary complaints: missed opportunities. J Adolesc Health. 2009;44(1):81–83. doi: 10.1016/j.jadohealth.2008.05.011
   PubMed Web of Science ®Google Scholar
• Tillman JL, Mark HD. HIV and STI testing in older adults: an integrative review. J Clin Nurs. 2015;24(15–16):2074–2095. doi: 10.1111/jocn.12797
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. FDA drug safety communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. 2016 [updated 2018 Sep 25; cited 2023 Jun6]. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-advises-restricting-fluoroquinolone-antibiotic-use-certain
   Google Scholar
• Michels TC, Sands JE. Dysuria: evaluation and differential diagnosis in adults. Am Fam Physician. 2015;92(9):778–786.
   PubMed Web of Science ®Google Scholar
• Melendez JH, Hsieh YH, Barnes M, et al. Can ciprofloxacin be used for precision treatment of gonorrhea in public STD clinics? Assessment of ciprofloxacin susceptibility and an opportunity for point-of-care testing. Pathogens. 2019;8(4):189.
   PubMed Web of Science ®Google Scholar
• Golparian D, Unemo M. Antimicrobial resistance prediction in Neisseria gonorrhoeae: current status and future prospects. Expert Rev Mol Diagn. 2022;22(1):29–48. doi: 10.1080/14737159.2022.2015329
   PubMed Web of Science ®Google Scholar
• Unemo M, Seifert HS, Hook EW 3rd, et al. Gonorrhoea. Nat Rev Dis Primers. 2019;5(1):79.
   PubMedGoogle Scholar
• Plager J, Judd A, Blumenthal K. Role of clinical history in beta-lactam hypersensitivity. Curr Opin Allergy Clin Immunol. 2021;21(4):320–326. doi: 10.1097/ACI.0000000000000758
   PubMed Web of Science ®Google Scholar
• Mitchell AB, Ness RA, Bennett JG, et al. Implementation and impact of a β-lactam allergy assessment protocol in a veteran population. Fed Pract. 2021;38:420–425. doi: 10.12788/fp.0172
   PubMedGoogle Scholar
• Adamson PC, Loeffelholz MJ, Klausner JD. Point-of-care testing for sexually transmitted infections: a review of recent developments. Arch Pathol Lab Med. 2020;144(11):1344–1351. doi: 10.5858/arpa.2020-0118-RA
   PubMed Web of Science ®Google Scholar
• Toskin I, Govender V, Blondeel K, et al. Call to action for health systems integration of point-of-care testing to mitigate the transmission and burden of sexually transmitted infections. Sex Transm Infect. 2020;96(5):342–347.
   PubMed Web of Science ®Google Scholar
• Binx IO CLIA-waived, point-of-care testing. That’s the binx io. 2023 [cited Jun 6, 2023]. Available from: https://mybinxhealth.com/point-of-care
   Google Scholar
• Naeem F, Karellis A, Nair S, et al. Multiplexed technologies for sexually transmitted infections: global evidence on patient-centered and clinical health outcomes. BMJ Glob Health. 2021;6(7):e005670.
   PubMed Web of Science ®Google Scholar
• Van Der Pol B, Taylor SN, Mena L et al. Evaluation of the performance of a point-of-care test for chlamydia and gonorrhea. JAMA Netw Open. 2020;3:e204819. doi: 10.1001/jamanetworkopen.2020.4819
   PubMed Web of Science ®Google Scholar
• Widdice LE, Hsieh YH, Silver B, et al. Performance of the atlas genetics rapid test for Chlamydia trachomatis and women’s attitudes toward point-of-care testing. Sex Transm Dis. 2018;45:723–727. doi: 10.1097/OLQ.0000000000000865
   PubMed Web of Science ®Google Scholar